Sublingual hematoma secondary to excessive anticoagulation is a rare, life-threatening condition. Reports in the literature have emphasized the importance of a prompt reversal of the causative coagulopathy by intravenous administration of vitamin K and fresh frozen plasma. In the event of an unstable airway, surgical intervention via tracheostomy or cricothyroidectomy is advocated. We report a case of sublingual hematoma that was treated conservatively, and we discuss the presentation and management of this entity.
Introduction
Sublingual hematoma is a rare complication of excessive anticoagulation. Its presenting features can mimic those of Ludwig angina, which is a severe form of cellulitis of the submaxillary space with secondary involvement of the sublingual and submental spaces; Ludwig angina is usually caused by a bacterial infection or a penetrating injury to the fl oor of the mouth. A failure to recognize the onset of a sublingual hematoma at an early stage can have potentially fatal consequences.
Th e fi rst reported case of a sublingual hematoma secondary to a coagulopathy was published in 1967 by Kiviranta. 1 In 1976, Lepore reported the fi rst case of warfarin-induced sublingual hematoma, which he called "pseudo-Ludwig phenomenon. " 2 Since then, only 13 cases of anticoagulation-induced sublingual and/or pha-ryngeal hematoma have been reported in the literature. In this article, we report a new case. We also discuss the role of clotting-factor concentrates such as vitamin K and fresh frozen plasma in conservative treatment, and we review the outcomes of previously reported cases. Given the rarity of sublingual hematoma, experience with such cases is limited, and no clear management guidelines exist in the literature.
Case report
A 57-year-old woman who was taking warfarin was referred to our service for management of suspected Ludwig angina. Her signs and symptoms included acute-onset sore throat, swelling of the neck and tongue, drooling, stridor at rest, and diffi culty speaking, all of which had developed over a 12-hour period (fi gure 1, A). She denied any history of trauma to the area. She had no associated epistaxis, meleana, or hematuria. Her medical history included hypertension and atrial fi brillation.
Findings on physical examination were remarkable for a large sublingual hematoma extending posteriorly to the tongue base and overlying the supraglottis (fi gure 1, B). Th e patient had exhibited good compliance with her warfarin regimen, and her international normalized ratio (INR) was ordinarily within the desired range (2.0 to 3.0). Upon admission, however, her INR was 9.0.
Based on the clinical presentation, physical examination, and elevated INR, the patient was diagnosed with a sublingual hematoma. Th e lack of severe cellulitis, the absence of septic markers such as an increased white blood cell count or erythrocyte sedimentation rate, and the grossly elevated INR helped to distinguish this case toms are oft en insidious and rapidly progressive. Some patients present with physical signs such as ecchymosis that are useful in establishing the diagnosis, but others, including our patient, do not exhibit telltale signs.
Patients with sublingual hematoma who are taking warfarin should be counseled about the possibility their condition may be the result of a drug or food interaction with their anticoagulation treatment. A history of good INR control does not preclude the possibility that excessive anticoagulation has occurred secondary to warfarin interactions with medications such as protein-binding agents (e.g., sulfonamides) and agents that inhibit warfarin metabolism (e.g., ciprofl oxacin, omeprazole, and ethanol). 5 In many of the previously reported cases of warfarininduced sublingual hematoma, management was largely conservative, involving a reversal of the coagulopathy by administration of vitamin K and either fresh frozen plasma (which was used in most cases) or coagulationfactor concentrates. Lim et al described the fi rst case of the successful use of a prothrombin complex concentrate (Beriplex) in a sublingual hematoma patient with a history of congestive cardiac failure. 6 While clotting-factor concentrates are more expensive than fresh frozen plasma, they do not need to be group-specifi c, they are not required in large amounts, and they do not need to thaw, so they can be given when a rapid reversal of coagulopathy is required. Intravenous vitamin K and fresh frozen plasma are generally used for less severe bleeding, and they provide a more gradual reversal. Th e currently recommended dose of fresh frozen plasma is 4 U for any patient whose INR is greater than 1.5. Th e recommended dose of prothrombin complex concentrate is 50 U/kg for patients whose INR is greater than 6.0. from Ludwig angina. She was managed conservatively in the intensive care unit with intravenous vitamin K and fresh frozen plasma. Her warfarin was stopped until her INR returned to normal; in the meantime, she was given subcutaneous enoxaparin at 1.5 mg/kg/ day. A satisfactory reversal of the anticoagulation was achieved within 36 hours (fi gure 2). No surgical intervention was required.
Discussion
Th e number of patients who are anticoagulated with warfarin has increased over the past decade. Th e incidence of hemorrhage in such patients is cited as 6.8%. 3 Warfarin is the most commonly prescribed anticoagulant medication in the U.K.; it is used by 0.5 to 1% of the population. 4 It is primarily indicated for patients with atrial fi brillation and those who have undergone placement of artifi cial heart valves. Warfarin acts by antagonizing the action of vitamin K, which is a cofactor in the hepatic synthesis of coagulation factors II, VII, and IX and proteins C and S. In addition to warfarin use, risk factors for sublingual hematoma include advanced age (>65 yr), hypertension, a history of stroke, concomitant use of various drugs, and alcohol consumption.
Sublingual hematomas develop as a result of submucosal bleeding, which can be triggered by minor trauma. Th ey can cause oropharyngeal symptoms and respiratory embarrassment. Recognition of this condition requires a high index of suspicion and a careful history. Sublingual hematomas typically develop quickly and extend posteriorly to involve the supraglottic larynx. Patients chiefl y complain of discomfort in the throat, drooling, swallowing diffi culty, and a change in voice. Th ere may also be associated diffi culty in breathing. Signs and symp- 
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Management in the intensive care setting is considered optimal. When clearance of the airway is required, a tracheostomy or cricothyroidectomy has been preferred over endotracheal intubation. [7] [8] [9] [10] [11] [12] Cohen and Warman advocated tracheostomy as the fi rst line of management. 12 Th e presence of a hematoma above the larynx makes intubation risky, especially in the absence of a clear view of the larynx. 1 Likewise, a tracheostomy performed with local anesthesia might lead to uncontrollable bleeding and present diffi culties in securing the airway. Our patient responded well to conservative management, but if she had experienced any deterioration in her condition, we would have resorted to surgical intervention with a tracheostomy or cricothyroidectomy.
In conclusion, sublingual hematoma is a rare but important possibility in patients on anticoagulation therapy who present with symptoms of the upper aerodigestive tract. Th e mainstays of management are prevention of airway compromise and a prompt reversal of the triggering coagulopathy. Based on our review of the literature, it would appear that each case of anticoagulation-induced upper aerodigestive tract hematoma must to be considered individually, as there are no published management guidelines. Th e patient's clinical picture and airway status will ultimately guide treatment.
. Figure 2 . Within 36 hours of conservative therapy, the neck swelling is resolved
